Clinical Trials Search
Contrast-Enhanced Ultrasound for the Evaluation of Changes in Tumor Blood Flow and the Surrounding Hepatic Parenchyma before, during and after Hepatic Artery Embolization
The purpose of the study is to find out if a study agent called Lumason® microbubbles may be helpful for people with lesions in the liver. It is possible it may help determine an early response to radioembolization and/or help demonstrate radiation toxicity to the surrounding liver.
Primary Objective: Prospectively acquire contrast-enhanced ultrasound (CEUS) scans following intravenous (IV) administration of Lumason® microbubbles in 25 patients with primary tumors in the liver. Secondary Objectives: Quantitative analysis of CEUS to predict tumor response to and liver toxicity from HAE.